Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes
Phase 3 SURPASS programme demonstrated that Mounjaro, whether used alone or with other diabetes medications, reduced A1C by up to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eli Lilly and Company
Eli Lilly appoints Winselow Tucker as President and General Manager for India
Winselow Tucker to lead Lilly India operations under the 'One India' strategic framework as Vineet Gupta transitions to a…
Lilly to establish new global capability centre in Hyderabad
The Lilly Capability Centre India is expected to open in mid-2025 and will focus on expanding capabilities in automation, AI,…
Industry reports 88 deals worth $11.1B in July 2024: GlobalData
The lifesciences sector also reported 73 VC deals worth $2.5 billion
US FDA to Review Eli Lilly’s Donanemab for Early Alzheimer’s Treatment
The meeting is set to be held on June 10, 2024
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Heart failure accounts for more than one million hospitalisations a year in the US
Bajaj Healthcare applies to Indian patent office for compulsory licence for Baricitinib
Considering Bajaj Healthcare's manufacturing capabilities and strong in-house R&D team, we can produce Baricitinib at very…
Mankind Pharma partners with BDR Pharma to distribute Baricitinib in India
BDR Pharma will be manufacturing and marketing the product under a royalty-free, limited and non-exclusive voluntary licence from…
European Commission approves Jardiance to treat heart failure
This new indication is based on the EMPEROR-Reduced trial, which showed a significant 25 per cent reduction in the combined…
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19
Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…